“No Smoke Does Not Mean No Harm” - And No Perspective Does Not Mean Public Health

The latest campaign from the World Health Organisation is visually polished, emotionally loaded, and entirely predictable. Fruit flavours, bright colours, alarmist slogans, and carefully crafted imagery all push the same implication: nicotine pouches are simply the tobacco industry’s latest sinister attempt to “hook” a new generation. World Health Organisation

But beneath the glossy aesthetics and moral panic sits a much deeper problem. The WHO increasingly speaks about nicotine as though every form of nicotine use exists in the same moral and public health category. Cigarettes, vapes, pouches, heated tobacco, nicotine gum, and oral nicotine products are flattened into a single narrative built around “industry manipulation,” “addiction,” and “youth targeting.” That framing may work politically and generate emotionally powerful headlines, but it does not reflect reality. And reality matters when combustible cigarettes still kill millions of people worldwide every year.

The WHO campaign repeatedly stresses that nicotine pouches are “flavoured and appealing” and that these products “evolve rapidly.” Yet what it barely acknowledges is why many adults use these products in the first place. People use nicotine pouches because they contain no smoke, no combustion, no tar, no ash, and no inhalation of burnt tobacco. That distinction is not minor. It is the entire point. The absence of combustion is the foundation of the harm reduction argument, because combustion is what makes smoking extraordinarily deadly.

Instead, the WHO presents the slogan “No smoke does not mean no harm” as though discovering reduced harm somehow invalidates harm reduction itself. The question has always been relative harm. Compared to what? Compared to smoking? Compared to inhaling burning tobacco dozens of times per day for decades? Compared to the leading preventable cause of death on Earth?

That comparison is the one many public health institutions increasingly avoid making clearly because once people understand the continuum of risk, prohibitionist messaging becomes much harder to sustain. Modern tobacco control often frames the entire debate around the hypothetical teenager while largely ignoring the existing adult smoker. The 45-year-old construction worker is desperately trying not to smoke anymore. The mother who switched after decades of smoking cigarettes. The person who failed repeatedly with patches, gum, and abstinence but finally found something that kept them away from combustible tobacco. Those people barely exist in WHO messaging now.

Instead, the conversation increasingly becomes ideological. If a product contains nicotine and is not medically pure, it is treated primarily as a threat. What is remarkable is how often public health campaigns now speak about reduced-risk nicotine products using language once reserved almost exclusively for cigarettes themselves. Words like “toxic,” “deadly,” “harmful,” and “engineered for addiction” are deployed with little effort to distinguish levels of risk. That creates a profound communication problem because when institutions blur distinctions too aggressively, people eventually stop trusting them altogether.

If the public hears that smoking kills, vaping kills, nicotine pouches are dangerous, and everything is essentially the same, many smokers will inevitably conclude that there is little point switching at all. “I may as well keep smoking” becomes the unintended takeaway. That may be one of the greatest failures of modern anti-nicotine absolutism.

The irony is staggering. For decades, tobacco control has argued that smokers struggled to quit because cigarettes delivered nicotine rapidly, efficiently, and ritualistically. Now that smoke-free nicotine products exist, which remove combustion from the equation, many of the same institutions appear deeply uncomfortable with the possibility that people might continue using nicotine without smoking. Not because nicotine itself is harmless, but because the cultural and ideological war against smoking gradually evolved into a war against nicotine itself.

That distinction matters enormously because if the genuine goal is reducing disease and death, then replacing combustible tobacco with substantially lower-risk alternatives should be viewed as a public health opportunity, not primarily as a public relations threat.

One of the most revealing aspects of the WHO report is not what it says, but what it leaves out. Missing almost entirely is any meaningful discussion of toxicological comparisons between nicotine pouches and cigarettes, or even comparisons between nicotine pouches and pharmaceutical nicotine products already accepted by public health systems. That omission matters because the science on these products is not nonexistent. Several toxicological assessments suggest nicotine pouches contain dramatically lower levels of harmful constituents than combustible tobacco and, in some cases, even lower levels than traditional nicotine replacement therapies.

A 2024 paper published in Tobacco Control found that nicotine pouches contained tobacco-specific nitrosamines at levels ranging from 0 to 13 nanograms per gram, compared with approximately 380 nanograms per gram found in nicotine gum. Tobacco Control study on nicotine pouches and nitrosamines. That is an extraordinary comparison when nicotine gum is routinely framed as an acceptable cessation aid while nicotine pouches are increasingly presented as an emerging public health menace.

The contradiction becomes even harder to ignore when looking at the U.S. FDA’s own scientific review documents related to ZYN nicotine pouches, which examined toxicological exposure and constituent levels in detail. FDA ZYN PMTA scientific review. None of this means nicotine pouches are harmless, but public health should be capable of communicating gradations of risk without collapsing into absolutist messaging. When institutions refuse to acknowledge meaningful differences between products, they distort consumer understanding rather than improve it.

Another major omission in the WHO narrative is how closely nicotine pouches resemble nicotine replacement therapies in terms of toxicological profile. A peer-reviewed review published in F1000Research concluded that nicotine pouches are comparable to nicotine replacement therapy products with respect to harmful and potentially harmful constituents. F1000Research review on nicotine pouches. That comparison alone should fundamentally change the tone of the debate. Instead, the public is presented with imagery and rhetoric that imply these products exist in roughly the same universe of risk as cigarettes themselves.

The WHO warns that flavours “hook” young people, but flavours also help adults move away from cigarettes. That is the part rarely discussed honestly. A smoker switching to mint, citrus, berry, or coffee-flavoured nicotine products is not evidence of corruption or manipulation. It may simply reflect the reality that many people do not want their alternative to taste like smoke and ash. Public health messaging increasingly treats flavour preference itself as suspicious, as though adults are only permitted to consume nicotine in grim, joyless, medicinal forms that maximise suffering and minimise satisfaction.

But people are human beings, not behavioural experiments. Pleasure influences behaviour. Convenience influences behaviour. Taste influences behaviour. Pretending otherwise has not eliminated nicotine use. It has merely distorted the policy conversation around it.

Even some experts reacting to the WHO report acknowledged a far more nuanced reality than the organisation’s public messaging suggests. In expert commentary collected by the Science Media Centre expert reaction page, three researchers stressed the importance of distinguishing nicotine pouches from combustible tobacco and considering relative risk in policy discussions. Some noted that while youth uptake should absolutely be monitored, nicotine pouches likely represent substantially lower risk than smoking and may have harm reduction potential for adults who smoke.

Prof. Polosa’s quote of the month

”If a form of nicotine consumption leads to little or no harm, why should it concern public health at all?”

That nuance is critical because there is a growing divide between the absolutist tone of institutional anti-nicotine campaigning and the more measured assessments coming from toxicologists, harm reduction researchers, and regulatory scientists. The WHO increasingly communicates as though the existence of any non-medical nicotine product is itself a policy failure. But millions of adults around the world are not waiting for perfect abstinence. They are simply looking for something that moves them away from cigarettes. And many of them are succeeding.

Meanwhile, prohibition-heavy approaches continue producing massive illicit markets around the world. Australia is a perfect example. One of the harshest nicotine regulatory systems in the developed world now coexists with a booming black market in disposable vapes, illicit tobacco, and unregulated nicotine products. Demand did not disappear. It never does.

Yet the WHO speaks constantly about “industry tactics” while rarely discussing policy failure, unintended consequences, or what happens when governments make safer nicotine alternatives excessively difficult to access while cigarettes remain legally available almost everywhere.

And perhaps that is the deepest frustration with campaigns like this. Not that they acknowledge risk, because risk exists. Not that they worry about youth uptake, because that concern is legitimate. The frustration is that they increasingly refuse to communicate proportionately. Everything becomes framed through fear, suspicion, and the assumption that adults cannot possibly make rational distinctions between products.

“No smoke means harm reduction.”